Adding to these, CoQ10 reduces oxidative damage that causes lung and brain diseases, muscle fatigue and skin damage
The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obese), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Contrave is an ideal option for: Adults looking for mild to moderate weight loss People who also have depression or binge eating disorder, Contrave may help with mood and cravings Those who prefer taking a daily pill instead of weekly injections Only approved for use in adults (18 and older) If you prefer tablets over injections or do not require significant weight loss (above 10%), Contrave may be right for you
If validated, GLP-1RAs could shift the landscape of diabetes management with an added advantage in cancer prevention
Patients with primary carnitine deficiency (PCD) usually have very low free carnitine levels in their blood
Activating glucagon receptors in cardiac tissue raises heart rate
